GSK Investigational Site
Madrid, Spain
1,342 recruiting
Showing 1–20 of 111 trials
Recruiting
Phase 3
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-Associated Steatohepatitis
GlaxoSmithKline1,740 enrolledNCT07701993
Recruiting
Phase 3
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-Associated Steatohepatitis
GlaxoSmithKline380 enrolledNCT07704892
Recruiting
Phase 3
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
GlaxoSmithKline54,000 enrolledNCT07805707
Recruiting
Phase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,250 enrolled43 locationsNCT07221188
Recruiting
Phase 1Phase 2
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Neoplasms, Prostate
GlaxoSmithKline85 enrolled19 locationsNCT06990880
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
NeoplasmsNeoplasms, Colorectal
GlaxoSmithKline47 enrolled22 locationsNCT07213609
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
Liver Diseases, Alcoholic
GlaxoSmithKline274 enrolledNCT07791043
Recruiting
Phase 1Phase 2
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Neoplasms, Prostate
GlaxoSmithKline54 enrolled11 locationsNCT07332455
Recruiting
Phase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
GlaxoSmithKline292 enrolled62 locationsNCT05757102
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline624 enrolledNCT07780669
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 4
Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Nasal Polyps
GlaxoSmithKline28 enrolledNCT07701967
Recruiting
Phase 3
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
GlaxoSmithKline450 enrolled124 locationsNCT07218926
Recruiting
Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Connective Tissue Diseases
GlaxoSmithKline514 enrolled10 locationsNCT06716606
Recruiting
Phase 2
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
Gastrointestinal Neoplasms
GlaxoSmithKline24 enrolledNCT07689201
Recruiting
Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Lung Diseases, Interstitial
GlaxoSmithKline440 enrolled131 locationsNCT06572384
Recruiting
Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Hypereosinophilic Syndrome
GlaxoSmithKline109 enrolled91 locationsNCT05334368
Recruiting
Phase 1
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline24 enrolledNCT07789899
Recruiting
Phase 3
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Neoplasms, Lung
GlaxoSmithKline420 enrolled126 locationsNCT07099898
Recruiting
Phase 3
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Neoplasms, Endometrial
GlaxoSmithKline600 enrolled18 locationsNCT07286331